Pharma & Biotech

Despite securing intellectual property rights that unlock access to a vast market of more than 200 million people, Bionxt Solutions...

The equity story for Hims & Hers is currently defined by a dramatic clash between persistent market anxieties and emerging...

Eli Lilly has achieved a monumental financial milestone, becoming the first pharmaceutical company ever to surpass a $1 trillion market...

Monopar Therapeutics Inc. (MNPR) experienced a dramatic upward move during Friday's trading, with its shares posting a substantial gain exceeding...

Enzo Biochem's longstanding presence on public markets has reached its definitive conclusion. The life sciences firm transitioned to private ownership...

The long wait for concrete validation appears to be over for InnoCan Pharma's stakeholders. The biotech firm has delivered a...

Facing intense competitive pressure, Danish pharmaceutical leader Novo Nordisk is executing a dramatic strategic pivot. With its shares down more...

The pharmaceutical sector has reached an unprecedented milestone as Eli Lilly becomes the first drugmaker to achieve a $1 trillion...

The investment case for Ocugen is under severe pressure as its stock experiences a dramatic downward spiral. With bearish investors...

Pharmaceutical titan Pfizer is aggressively reshaping its identity beyond being perceived as a pandemic beneficiary, making a substantial strategic commitment...